Hypoxia drives transient site-specific copy gain and drug-resistant gene expression

Joshua C. Black, Elnaz Atabakhsh, Jaegil Kim, Kelly M. Biette, Capucine Van Rechem, Brendon Ladd, Paul D. Burrowes, Carlos Donado, Hamid Mattoo, Benjamin P. Kleinstiver, Bing Song, Grasiella Andriani, J. Keith Joung, Othon Iliopoulos, Cristina Montagna, Shiv Pillai, Gad Getz, Johnathan R. Whetstine

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Copy number heterogeneity is a prominent feature within tumors. The molecular basis for this heterogeneity remains poorly characterized. Here, we demonstrate that hypoxia induces transient site-specific copy gains (TSSGs) in primary, nontransformed, and transformed human cells. Hypoxia-driven copy gains are not dependent on HIF1α or HIF2α; however, they are dependent on the KDM4A histone demethylase and are blocked by inhibition of KDM4A with a small molecule or the natural metabolite succinate. Furthermore, this response is conserved at a syntenic region in zebrafish cells. Regions with site-specific copy gain are also enriched for amplifications in hypoxic primary tumors. These tumors exhibited amplification and overexpression of the drug resistance gene CKS1B, which we recapitulated in hypoxic breast cancer cells. Our results demonstrate that hypoxia provides a biological stimulus to create transient site-specific copy alterations that could result in heterogeneity within tumors and cell populations. These findings have major implications in our understanding of copy number heterogeneity and the emergence of drug resistance genes in cancer.

Original languageEnglish (US)
Pages (from-to)1018-1031
Number of pages14
JournalGenes and Development
Volume29
Issue number10
DOIs
StatePublished - 2015

Fingerprint

Gene Expression
Drug Resistance
Pharmaceutical Preparations
Neoplasms
Histone Demethylases
Neoplasm Genes
Succinic Acid
Zebrafish
Breast Neoplasms
Hypoxia
Population
Genes

Keywords

  • CNV
  • Hypoxia
  • JmjC
  • KDM4A
  • Site-specific copy gain
  • Tumor heterogeneity

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Black, J. C., Atabakhsh, E., Kim, J., Biette, K. M., Van Rechem, C., Ladd, B., ... Whetstine, J. R. (2015). Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. Genes and Development, 29(10), 1018-1031. https://doi.org/10.1101/gad.259796.115

Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. / Black, Joshua C.; Atabakhsh, Elnaz; Kim, Jaegil; Biette, Kelly M.; Van Rechem, Capucine; Ladd, Brendon; Burrowes, Paul D.; Donado, Carlos; Mattoo, Hamid; Kleinstiver, Benjamin P.; Song, Bing; Andriani, Grasiella; Keith Joung, J.; Iliopoulos, Othon; Montagna, Cristina; Pillai, Shiv; Getz, Gad; Whetstine, Johnathan R.

In: Genes and Development, Vol. 29, No. 10, 2015, p. 1018-1031.

Research output: Contribution to journalArticle

Black, JC, Atabakhsh, E, Kim, J, Biette, KM, Van Rechem, C, Ladd, B, Burrowes, PD, Donado, C, Mattoo, H, Kleinstiver, BP, Song, B, Andriani, G, Keith Joung, J, Iliopoulos, O, Montagna, C, Pillai, S, Getz, G & Whetstine, JR 2015, 'Hypoxia drives transient site-specific copy gain and drug-resistant gene expression', Genes and Development, vol. 29, no. 10, pp. 1018-1031. https://doi.org/10.1101/gad.259796.115
Black JC, Atabakhsh E, Kim J, Biette KM, Van Rechem C, Ladd B et al. Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. Genes and Development. 2015;29(10):1018-1031. https://doi.org/10.1101/gad.259796.115
Black, Joshua C. ; Atabakhsh, Elnaz ; Kim, Jaegil ; Biette, Kelly M. ; Van Rechem, Capucine ; Ladd, Brendon ; Burrowes, Paul D. ; Donado, Carlos ; Mattoo, Hamid ; Kleinstiver, Benjamin P. ; Song, Bing ; Andriani, Grasiella ; Keith Joung, J. ; Iliopoulos, Othon ; Montagna, Cristina ; Pillai, Shiv ; Getz, Gad ; Whetstine, Johnathan R. / Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. In: Genes and Development. 2015 ; Vol. 29, No. 10. pp. 1018-1031.
@article{300993f1691243d8b35cac925e47a307,
title = "Hypoxia drives transient site-specific copy gain and drug-resistant gene expression",
abstract = "Copy number heterogeneity is a prominent feature within tumors. The molecular basis for this heterogeneity remains poorly characterized. Here, we demonstrate that hypoxia induces transient site-specific copy gains (TSSGs) in primary, nontransformed, and transformed human cells. Hypoxia-driven copy gains are not dependent on HIF1α or HIF2α; however, they are dependent on the KDM4A histone demethylase and are blocked by inhibition of KDM4A with a small molecule or the natural metabolite succinate. Furthermore, this response is conserved at a syntenic region in zebrafish cells. Regions with site-specific copy gain are also enriched for amplifications in hypoxic primary tumors. These tumors exhibited amplification and overexpression of the drug resistance gene CKS1B, which we recapitulated in hypoxic breast cancer cells. Our results demonstrate that hypoxia provides a biological stimulus to create transient site-specific copy alterations that could result in heterogeneity within tumors and cell populations. These findings have major implications in our understanding of copy number heterogeneity and the emergence of drug resistance genes in cancer.",
keywords = "CNV, Hypoxia, JmjC, KDM4A, Site-specific copy gain, Tumor heterogeneity",
author = "Black, {Joshua C.} and Elnaz Atabakhsh and Jaegil Kim and Biette, {Kelly M.} and {Van Rechem}, Capucine and Brendon Ladd and Burrowes, {Paul D.} and Carlos Donado and Hamid Mattoo and Kleinstiver, {Benjamin P.} and Bing Song and Grasiella Andriani and {Keith Joung}, J. and Othon Iliopoulos and Cristina Montagna and Shiv Pillai and Gad Getz and Whetstine, {Johnathan R.}",
year = "2015",
doi = "10.1101/gad.259796.115",
language = "English (US)",
volume = "29",
pages = "1018--1031",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "10",

}

TY - JOUR

T1 - Hypoxia drives transient site-specific copy gain and drug-resistant gene expression

AU - Black, Joshua C.

AU - Atabakhsh, Elnaz

AU - Kim, Jaegil

AU - Biette, Kelly M.

AU - Van Rechem, Capucine

AU - Ladd, Brendon

AU - Burrowes, Paul D.

AU - Donado, Carlos

AU - Mattoo, Hamid

AU - Kleinstiver, Benjamin P.

AU - Song, Bing

AU - Andriani, Grasiella

AU - Keith Joung, J.

AU - Iliopoulos, Othon

AU - Montagna, Cristina

AU - Pillai, Shiv

AU - Getz, Gad

AU - Whetstine, Johnathan R.

PY - 2015

Y1 - 2015

N2 - Copy number heterogeneity is a prominent feature within tumors. The molecular basis for this heterogeneity remains poorly characterized. Here, we demonstrate that hypoxia induces transient site-specific copy gains (TSSGs) in primary, nontransformed, and transformed human cells. Hypoxia-driven copy gains are not dependent on HIF1α or HIF2α; however, they are dependent on the KDM4A histone demethylase and are blocked by inhibition of KDM4A with a small molecule or the natural metabolite succinate. Furthermore, this response is conserved at a syntenic region in zebrafish cells. Regions with site-specific copy gain are also enriched for amplifications in hypoxic primary tumors. These tumors exhibited amplification and overexpression of the drug resistance gene CKS1B, which we recapitulated in hypoxic breast cancer cells. Our results demonstrate that hypoxia provides a biological stimulus to create transient site-specific copy alterations that could result in heterogeneity within tumors and cell populations. These findings have major implications in our understanding of copy number heterogeneity and the emergence of drug resistance genes in cancer.

AB - Copy number heterogeneity is a prominent feature within tumors. The molecular basis for this heterogeneity remains poorly characterized. Here, we demonstrate that hypoxia induces transient site-specific copy gains (TSSGs) in primary, nontransformed, and transformed human cells. Hypoxia-driven copy gains are not dependent on HIF1α or HIF2α; however, they are dependent on the KDM4A histone demethylase and are blocked by inhibition of KDM4A with a small molecule or the natural metabolite succinate. Furthermore, this response is conserved at a syntenic region in zebrafish cells. Regions with site-specific copy gain are also enriched for amplifications in hypoxic primary tumors. These tumors exhibited amplification and overexpression of the drug resistance gene CKS1B, which we recapitulated in hypoxic breast cancer cells. Our results demonstrate that hypoxia provides a biological stimulus to create transient site-specific copy alterations that could result in heterogeneity within tumors and cell populations. These findings have major implications in our understanding of copy number heterogeneity and the emergence of drug resistance genes in cancer.

KW - CNV

KW - Hypoxia

KW - JmjC

KW - KDM4A

KW - Site-specific copy gain

KW - Tumor heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=84929578889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929578889&partnerID=8YFLogxK

U2 - 10.1101/gad.259796.115

DO - 10.1101/gad.259796.115

M3 - Article

VL - 29

SP - 1018

EP - 1031

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 10

ER -